STOCK TITAN

Endo to Host Investor Call on Second Quarter 2024 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Endo, Inc. (OTCQX: NDOI) has announced that it will release its second quarter 2024 financial results on August 27, 2024, before the market opens. The company's senior management team will host a conference call and live webcast for investors at 8:00 a.m. ET on the same day. Investors can participate by dialing 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.), or by joining the live webcast through a provided link. Participants are advised to join 10 minutes before the scheduled start time. A replay of the webcast will be available within 24 hours on the company's investor relations website.

Loading...
Loading translation...

Positive

  • Timely disclosure of quarterly financial results
  • Providing multiple options for investor participation (phone and webcast)
  • Offering a replay option for increased accessibility

Negative

  • None.

News Market Reaction – NDOI

%
1 alert
% News Effect

On the day this news was published, NDOI declined NaN%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

MALVERN, Pa., Aug. 7, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will release its second quarter 2024 financial results on August 27, 2024, prior to market open. Members of Endo's senior management team will host a conference call and live webcast for investors at 8:00 a.m. ET.

To participate in the call, please dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.) or join the live webcast at this link. Please join 10 minutes prior to the scheduled start time.

A replay of the webcast will be available within 24 hours at investor.endo.com.

About Endo
Endo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/endo-to-host-investor-call-on-second-quarter-2024-financial-results-302216951.html

SOURCE Endo, Inc.

FAQ

When will Endo (NDOI) release its Q2 2024 financial results?

Endo (NDOI) will release its second quarter 2024 financial results on August 27, 2024, prior to market open.

What time is Endo's (NDOI) Q2 2024 earnings call scheduled for?

Endo's (NDOI) Q2 2024 earnings call is scheduled for 8:00 a.m. ET on August 27, 2024.

How can investors participate in Endo's (NDOI) Q2 2024 earnings call?

Investors can participate in Endo's (NDOI) Q2 2024 earnings call by dialing 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.), or by joining the live webcast through the provided link.

Will there be a replay available for Endo's (NDOI) Q2 2024 earnings call?

Yes, a replay of the webcast for Endo's (NDOI) Q2 2024 earnings call will be available within 24 hours at investor.endo.com.
Endo Inc

OTC:NDOI

NDOI Rankings

NDOI Latest News

NDOI Stock Data

1.80B
40.36M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Malvern